Latest Capital Markets News

Zenith Minerals reported a 40% increase in its Dulcie Far North gold resource and secured A$2.48 million in new funding, positioning the company for aggressive exploration across its Australian gold and lithium projects.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

American Rare Earths advances its Halleck Creek Project with record high-grade drilling results, a strategic collaboration with BMO Capital Markets, and a significant state grant, reinforcing its role in securing the U.S. rare earth supply chain.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

OzAurum Resources reports a dynamic quarter with fresh drilling targets at Mulgabbie, high-grade gold at Patricia, and promising niobium anomalies in Brazil, supported by a $1 million capital raise.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

Odessa Minerals has completed key heritage and radiation surveys at its Lyndon Uranium Project and secured $1.1 million in new funding from prominent investors, positioning the company for a focused 2025 exploration campaign.

Pioneer Lithium Limited has lifted its trading suspension following the announcement of a proposed material acquisition and capital raising, signaling a pivotal moment for the company’s growth strategy.

Bellavista Resources has secured nearly A$5 million in capital to fund due diligence on advanced precious and base metal projects, while maintaining a strong cash position and progressing exploration at its Brumby Deposit.

ioneer Ltd’s December 2024 quarterly cash flow report reveals ongoing cash outflows from operations and investing, with nearly $4.5 million spent this quarter but a solid cash reserve providing a runway of almost five quarters.